Choroidal Neovascularization and Haller Vessel Morphology Associated with Vision and Treatment Number after 1 Year in Age-related Macular Degeneration
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The present study aimed to quantify various factors of vessel morphology, including vessel diameter, length, andcomplexity (fractal dimension and lacunarity) of both choroidal neovascularization (CNV) and en face Haller vessels using opticalcoherence tomography angiography (OCTA) and en face structural optical coherence tomography in typical neovascularage-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV) and to identify factors associatedwith visual acuity (VA) loss and number of injections within a year after the day of OCTA. Methods: We retrospectively analyzed 43 eyes of nAMD patients and 33 eyes of PCV patients whose OCTA was performedat least 12 months after an initial anti-vascular endothelial growth factor treatment. Quantitative parameters, including vesselarea, vessel diameter, vessel length, fractal dimension, and lacunarity were analyzed from en face images of CNV andHaller vessels. Clinical information, including logarithm of the minimum angle of resolution visual acuity and injection numberof anti-vascular endothelial growth factor were acquired after 12 months from OCTA date. Using logistic regression analyses,parameters associated with logarithm of the minimum angle of resolution VA loss of 0.2 or more (VA loss group) and a numberof injections of four or more (unstable group) after 12 months were analyzed. Results: In typical nAMD, the VA loss group was associated with a smaller number of intersections of Haller vessels. The unstablegroup was associated with an increased lacunarity of CNV in typical nAMD. In PCV, both VA loss and unstable groupswere associated with a higher maximal diameter of Haller vessels. Conclusions: VA loss and injection number of nAMD and PCV 12 months after OCTA imaging were associated with differentmorphological parameters of CNV and Haller vessels. Therefore, quantitative analyses of both CNV and Haller vessels fromOCTA and en face optical coherence tomography might provide prognostic information about visual outcome and injectionfrequency within 12 months after OCTA imaging.
Abstract
Purpose: The present study aimed to quantify various factors of vessel morphology, including vessel diameter, length, andcomplexity (fractal dimension and lacunarity) of both choroidal neovascularization (CNV) and en face Haller vessels using opticalcoherence tomography angiography (OCTA) and en face structural optical coherence tomography in typical neovascularage-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV) and to identify factors associatedwith visual acuity (VA) loss and number of injections within a year after the day of OCTA. Methods: We retrospectively analyzed 43 eyes of nAMD patients and 33 eyes of PCV patients whose OCTA was performedat least 12 months after an initial anti-vascular endothelial growth factor treatment. Quantitative parameters, including vesselarea, vessel diameter, vessel length, fractal dimension, and lacunarity were analyzed from en face images of CNV andHaller vessels. Clinical information, including logarithm of the minimum angle of resolution visual acuity and injection numberof anti-vascular endothelial growth factor were acquired after 12 months from OCTA date. Using logistic regression analyses,parameters associated with logarithm of the minimum angle of resolution VA loss of 0.2 or more (VA loss group) and a numberof injections of four or more (unstable group) after 12 months were analyzed. Results: In typical nAMD, the VA loss group was associated with a smaller number of intersections of Haller vessels. The unstablegroup was associated with an increased lacunarity of CNV in typical nAMD. In PCV, both VA loss and unstable groupswere associated with a higher maximal diameter of Haller vessels. Conclusions: VA loss and injection number of nAMD and PCV 12 months after OCTA imaging were associated with differentmorphological parameters of CNV and Haller vessels. Therefore, quantitative analyses of both CNV and Haller vessels fromOCTA and en face optical coherence tomography might provide prognostic information about visual outcome and injectionfrequency within 12 months after OCTA imaging.
참고문헌 (18)
- Pauleikhoff D, "Neovascular age-related macular degeneration:natural history and treatment outcomes", Retina, 25, pp.1065~1084 (2005)
- Pang CE, "Pachychoroid neovasculopathy", Retina, 35, pp.1~9 (2015)
- Cheung CM, "Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management", Ophthalmology, 125, pp.708~724 (2018)
- Cheung CM, "Pachychoroid disease", Eye (Lond), 33, pp.14~33 (2019)
- Kuehlewein L, "Optical coherence tomography angiography of type 1 neovascularization in age-related macular degeneration", Am J Ophthalmol, 160, pp.739~748 (2015)
- Roberts PK, "Semiautomated quantitative approach to characterize treatment response in neovascular age-related macular degeneration: a real-world study", Retina, 37, pp.1492~1498 (2017)
- Xu D, "Long-term progression of type 1 neovascularization in age-related macular degeneration using optical coherence tomography angiography", Am J Ophthalmol, 187, pp.10~20 (2018)
- Coscas F, "Quantitative optical coherence tomography angiography biomarkers for neovascular age-related macular degeneration in remission", PLoS One, 13, pp.e0205513~ (2018)
- Choi M, "OCT angiography features of neovascularization as predictive factors for frequent recurrence in age-related macular degeneration", Am J Ophthalmol, 213, pp.109~119 (2020)
- Baek J, "Choriocapillaris flow impairments in association with pachyvessel in early stages of pachychoroid", Sci Rep, 9, pp.5565~ (2019)
- Lee H, "Association of treatment response with quantitative changes in choroidal neovascularization and choroidal vessel in neovascular age-related macular degeneration", Retina, 40, pp.1704~1718 (2020)
- Schneider CA, "NIH image to ImageJ:25 years of image analysis", Nat Methods, 9, pp.671~675 (2012)
- Hotaling NA, "DiameterJ:a validated open source nanofiber diameter measurement tool", Biomaterials, 61, pp.327~338 (2015)
- Karperien A, "Quantitating the subtleties of microglial morphology with fractal analysis", Front Cell Neurosci, 7, pp.3~ (2013)
- Plotnick RE, "Lacunarity analysis: a general technique for the analysis of spatial patterns", Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics, 53, pp.5461~5468 (1996)
- Sutera SP, "The history of Poiseuille’s law", Annu Rev Fluid Mech, 25, pp.1~19 (1993)
- Dansingani KK, "En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography", Retina, 36, pp.499~516 (2016)
- Al-Sheikh M, "Biomarkers of neovascular activity in age-related macular degeneration using optical coherence tomography angiography", Retina, 38, pp.220~230 (2018)